Literature DB >> 1825866

Laparoscopic excision of ovarian neoplasms subsequently found to be malignant.

M Maiman1, V Seltzer, J Boyce.   

Abstract

One hundred fifty-six members and candidate members of the Society of Gynecologic Oncologists responded to a survey concerning the "laparoscopic management of ovarian neoplasms subsequently found to be malignant." Twenty-nine responders (19%) reported a total of 42 cases of ovarian malignancy. The laparoscopic procedure was aborted or the cyst was aspirated in 38% of the cases, and partial or complete excisions were attempted in 33 and 29%, respectively. The characteristics of the masses were as follows: less than 8 cm 67%, cystic 62%, unilocular 48%, and unilateral 81%. All four "benign" characteristics were present in 31% of the cases found to be malignant, and three of four characteristics were present in 24%. Laparotomy was performed at the time of laparoscopy in 17% of cases, after laparoscopy in 71% with an average interval of 4.8 weeks, and not at all in 12%. Fifty-seven percent of the cases were invasive epithelial malignancies, whereas 29% were tumors of low malignant potential. At least 50% of the patients had stages II-IV. We conclude that attempted laparoscopic excisions of adnexal masses that are subsequently found to be malignant are not uncommon, and that the presence of so-called "benign" characteristics does not preclude malignancy. Attempts at partial or complete excision are common, as are delays in subsequent definitive surgery. The stage of disease is often advanced, and all histologic types of malignancy are encountered. We advocate careful evaluation of this practice, with development of strict guidelines to ensure optimal patient care.

Entities:  

Mesh:

Year:  1991        PMID: 1825866

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  13 in total

1.  Performance of laparoscopy in identifying malignant ovarian cysts.

Authors:  C Bensaid; M A Le Frère Belda; U Metzger; F Larousserie; D Clément; G Chatellier; F Lécuru
Journal:  Surg Endosc       Date:  2006-06-26       Impact factor: 4.584

2.  Posterior colpotomy: a successful retrieval route for pelvic masses following robot-assisted laparoscopic surgery.

Authors:  Gerald Feuer; Stephanie Yap; Patricia Hernandez
Journal:  J Robot Surg       Date:  2011-08-30

3.  Single-port-access, hand-assisted laparoscopic surgery for benign large adnexal tumors versus single-port pure laparoscopic surgery for adnexal tumors.

Authors:  Hyun-Jin Roh; Soo-Jeong Lee; Jun-Woo Ahn; Yong-Soon Kwon; Hyun-Jin Cho; Dae-Yeon Kim
Journal:  Surg Endosc       Date:  2011-10-25       Impact factor: 4.584

4.  [Contra endoscopic ovarian surgery].

Authors:  G Kindermann
Journal:  Arch Gynecol Obstet       Date:  1995       Impact factor: 2.344

5.  [Endoscopic surgery: from the possible to the sensible].

Authors:  B Schüssler
Journal:  Arch Gynecol Obstet       Date:  1994       Impact factor: 2.344

Review 6.  [Problems associated with extraction of tumors in surgical celioscopy].

Authors:  P Sauthier; S Spuhler; P De Grandi
Journal:  Arch Gynecol Obstet       Date:  1993       Impact factor: 2.344

Review 7.  Laparoscopy versus laparotomy for FIGO stage I ovarian cancer.

Authors:  Frederico S Falcetta; Theresa A Lawrie; Lídia Rf Medeiros; Maria Ines da Rosa; Maria I Edelweiss; Airton T Stein; Alice Zelmanowicz; Anaelena B Moraes; Roselaine R Zanini; Daniela D Rosa
Journal:  Cochrane Database Syst Rev       Date:  2016-10-13

8.  Laparoscopic management of adnexal masses.

Authors:  E Serur; P L Emeney; D W Byrne
Journal:  JSLS       Date:  2001 Apr-Jun       Impact factor: 2.172

9.  Adnexal masses suspected to be benign treated with laparoscopy.

Authors:  Richard H Demir; Greg J Marchand
Journal:  JSLS       Date:  2012 Jan-Mar       Impact factor: 2.172

10.  Prognostic factors in early-stage ovarian cancer.

Authors:  Germana Tognon; Mario Carnazza; Monica Ragnoli; Stefano Calza; Federico Ferrari; Angela Gambino; Valentina Zizioli; Sara Notaro; Benedetta Sostegni; Enrico Sartori
Journal:  Ecancermedicalscience       Date:  2013-06-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.